<DOC>
	<DOCNO>NCT01445262</DOCNO>
	<brief_summary>This post-marketing surveillance study ( PMS ) conduct collect safety efficacy data among subject allergic rhinitis , urticaria , eczema , dermatitis , skin irritation , prurigo pruritus cutaneous never treat levocetirizine tablet .</brief_summary>
	<brief_title>Drug Use Investigation XYZALÂ®</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis , Allergic , Perennial</mesh_term>
	<mesh_term>Levocetirizine</mesh_term>
	<mesh_term>Cetirizine</mesh_term>
	<criteria>Must first time take levocetirizine tablet As PMS study , exclusion criterion .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>